Medtech
Custom medical implant firm Restore3d acquires Massachusetts-based company
Restore3d, which provides custom-made surgical implants and recently raised $12 million in new capital, is acquiring Massachusetts-based Conformis in an…
DURHAM – Restore3d, which provides custom-made surgical implants and recently raised $12 million in new capital, is acquiring Massachusetts-based Conformis in an all-cash deal.
Conformis, with a market cap of some $8.6 million at the time the sale was announced on Thursday, is publicly traded (Nasdaq: CFMS). Its stock rose more than 90% after the deal announcement to more than $2.
Custom surgical implant startup using AI lands 96 investors for $12M in new cash
The sale price is $2.27 per share in cash.
“This combination will create a leading personalized 3D-printed medical device company. Together, we share a common belief in the power of personalization. By leveraging the strengths in our respective portfolios around artificial-intelligence-driven implant design, digital automation, and 3D printed osseointegrative biomaterials, we see tremendous opportunity to offer clinically differentiated and cost-effective solutions across the orthopedic landscape, including shoulder, foot & ankle, spine, and large joints,” stated Kurt Jacobus, Chief Executive Officer of restor3d, in a statement.
The deal is expected to close by the end of the third quarter.
Conformis shares have fallen sharply over the past year, down from a price of more than $9.
The post Custom medical implant firm Restore3d acquires Massachusetts-based company first appeared on WRAL TechWire.
ETF Talk: AI is ‘Big Generator’
Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…
Apple gets an appeals court win for its Apple Watch
Apple has at least a couple more weeks before it has to worry about another sales ban.
Federal court blocks ban on Apple Watches after Apple appeal
A federal appeals court has temporarily blocked a sweeping import ban on Apple’s latest smartwatches while the patent dispute winds its way through…
